ResMed Inc. stock heads into the open after a 0.4% dip
Published on 09/08/2026 at 07:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
ResMed Inc. stock closed at USD 228.35 on the NYSE on September 4, 2026, down 0.37% from the prior session according to market data.MarketScreener That move left the shares modestly weaker over the last five trading days and slightly lower year to date at that point. The latest figures also show the stock trading below the average analyst target near USD 240, indicating a limited implied upside based on existing coverage.MarketBeat In addition, investors are now positioning around a declared dividend that will be paid later in September 2026.FinScry
September 4, 2026 in numbers
ResMed Inc. (ISIN US7611521078, NYSE: RMD) saw its stock finish at USD 228.35 on September 4, 2026, with a daily loss of 0.37%, as shown in NYSE closing data.MarketScreener Over the preceding five trading days the shares were down about 0.37%, while the performance since the start of 2026 stood around minus 4.89%, underscoring a challenging phase despite resilient demand for sleep and respiratory care equipment.MarketScreener At that closing level the stock traded below the consensus analyst price objective of roughly USD 240.31, a gap of around USD 11.96 or just over 5%, based on compiled broker estimates.MarketBeat
Recent analyst and investor positioning has highlighted that ResMed remains under valuation scrutiny, with some investors adding to positions following the latest reporting season.Motley Fool Australia Commentary from the brokerage community stresses that continuous positive demand for CPAP therapy and related devices has supported the company’s earnings trajectory, while concerns about the impact of GLP-1 weight-loss drugs on long-term sleep apnea treatment volumes may be overstated.Motley Fool Australia In this context, the modest decline on September 4, 2026 came against a backdrop of broader healthcare sector rotation, as investors reassessed exposure to medical technology names after the latest batch of quarterly results.Motley Fool Australia
Dividend and sector signals today
Looking at today, September 8, 2026, one key reference point for ResMed is its upcoming dividend payment: an ordinary dividend recorded on August 20, 2026 is scheduled to be paid on September 24, 2026, giving shareholders a dated cash return later this month.FinScry That payout, alongside the company’s earlier FY2026 results release, helps frame expectations for income and capital allocation, even though the precise yield remains modest relative to the share price near the recent USD 228 range.SquawkNews Sector commentary also notes that renewed investor interest in healthcare and sleep-disorder treatment is emerging after the reporting season, which could influence trading in ResMed as investors weigh growth prospects against valuation and competitive dynamics.Motley Fool Australia With the US session still ahead, the stock’s next move will depend on how traders digest these dividend and sector signals within a broader medical-technology landscape.
